AndreaBozzo/ceres-open-data-index huggingface dataset:
Appearance before Standing Committee on Access to Information, Privacy, and Ethics (ETHI) of May 10, 2021 on Facial Recognition Technology

Briefing binder used by the Privacy Commissioner of Canada, Daniel Therrien, as a witness before the Standing Committee on ETHI on May 10, 2021 on Facial Recognition Technology.

Organization: Office of the Privacy Commissioner of Canada | Commissariat à la protection de la vie privée du Canada
Appearance before Standing Committee on Access to Information, Privacy, and Ethics (ETHI) of May 10, 2021 on the Main Estimates 2021-22

Briefing binder used by the Privacy Commissioner of Canada, Daniel Therrien, as a witness before the Standing Committee on ETHI on May 10, 2021 on the Main Estimates.

Organization: Office of the Privacy Commissioner of Canada | Commissariat à la protection de la vie privée du Canada
Appearance of the Privacy Commissioner of Canada, Daniel Therrien before the Standing Committee on Industry, Science and Technology (INDU) – Study of the Canadian response to the COVID-19 pandemic

Briefing binder used by the Privacy Commissioner of Canada, Daniel Therrien, as a witness before the Standing Committee on INDU on May 29, 2020 on the Canadian Response to the COVID-19 Pandemic.

Organization: Office of the Privacy Commissioner of Canada | Commissariat à la protection de la vie privée du Canada
Blueprint for Action: Preventing substance-related harms among youth through a Comprehensive School Health approach

Schools are an important environment for youth. They are a setting for learning, personal and community development, socialization and the promotion of health and well-being. The COVID-19 pandemic has highlighted the significance of school communities in the lives of young people and their families, as well as their central place in our society. In recent years, there has also been greater attention on the role of schools in addressing substance use and substance-related harms among youth.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Preventing substance-related harms among Canadian youth through action within school communities: A policy paper

Recent years have seen unprecedented political and public attention on substance use among youth. In Canada, the legalization of non-medical cannabis use, rising numbers of opioid-related deaths and increases in the use of vaping products among youth are some of the factors that have led to the emergence of substance use as a priority concern.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
COVID-19: Effectiveness and benefits of vaccination

Vaccination is one of the most effective ways to protect our families, communities and ourselves against COVID-19. Evidence indicates that vaccines are very effective at preventing severe illness, hospitalization and death from COVID-19, including against Alpha and Delta variants of concern. However, there’s a small percentage of the population who are vaccinated that will still be infected with COVID-19 if they’re exposed to the virus.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Injury in review, 2020 edition: Spotlight on traumatic brain injuries across the life course

This is the third report of the Public Health Agency of Canada's (PHAC) Injury in Review series, providing important national surveillance statistics on the causes of traumatic brain injuries (TBI) across the life course, including sports, seniors' falls, assaults, consumer products, and more.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
National laboratory surveillance of invasive streptococcal disease in Canada - Annual summary 2019

3,673 isolates causing invasive pneumococcal disease (IPD) were characterized in 2019. Incidence rate of IPD for 2019 for children under <1 year of age is 13.2 cases per 100,000 population and for seniors ≥60 years to 21.2 cases per 100,000 population. The overall crude incidence rate has remained stable averaging 10.0 cases per 100,000 population since 2009.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Public Health Agency of Canada Quarterly Financial Report - For the quarter ended June 30, 2021

This quarterly financial report has been prepared by management as required by section 65.1 of the Financial Administration Act, in the form and manner prescribed by the Directive on Accounting Standards, GC 4400 Departmental Quarterly Financial Report. This quarterly financial report should be read in conjunction with the Main Estimates and Supplementary Estimates. Please note that this quarterly financial report has not been subject to an external audit or review.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
COVID-19 quarantine compliance and enforcement (Compliance Call Campaign 4.0 and 5.0): Privacy compliance evaluation

Due to the COVID-19 pandemic, enhanced border measures authorized by the Quarantine Act were introduced. These measures ensure appropriate actions are taken to reduce the spread of the virus. To verify and improve compliance with the Emergency Orders under the Quarantine Act, the Public Health Agency of Canada (PHAC) launched the COVID-19 Quarantine Compliance Call Campaign.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
COVID-19 for heath professionals: Post COVID-19 condition

The World Health Organization (WHO) refers to symptoms lasting for weeks or months after a COVID-19 infection as post COVID-19 condition. Some studies have reported later symptoms in patients with a severe COVID-19 infection. For example, those who were hospitalized or needed intensive care during recovery. However, post COVID-19 condition may also occur for people with mild or asymptomatic infection who were asked to isolate at home during the infectious phase.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
COVID-19: Recommendations for those vaccinated with vaccines not authorized by Health Canada for those staying in Canada to live, work or study

The Public Health Agency of Canada’s (PHAC) COVID-19 immunization recommendations for individuals previously vaccinated with COVID-19 vaccines not authorized by Health Canada is intended to support local, territorial, and provincial, decision-making by public health departments and health care professionals. Provinces and territories are responsible for designing and delivering immunization programs in their regions. PHAC’s immunization recommendations for previously immunized individuals does not impact the Government of Canada’s definition of fully vaccinated travellers or current border requirements, such as quarantine and testing.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
The Health Behaviour in School-aged Children (HBSC) study in Canada

The HBSC is a World Health Organization, on-going, cross-national research study of youth aged 11 to 15 years old that collects data every 4 years. The study aims to gain insight into young people's: well-being; health behaviours; and social contexts.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Suicide Prevention Framework

The Framework contributes to the implementation of the Mental Health Strategy for Canada: Changing Directions, Changing Lives, which is focused on improving the mental health and well-being of all Canadians. It also aligns with the First Nations Mental Wellness Continuum Framework (the Continuum) which is designed to help partners work more effectively with federal, provincial and territorial programs within a comprehensive mental wellness system for First Nations 

The Framework is informed by the World Health Organization's Preventing Suicide: A Global Imperative report, which reinforces the value of a public health approach to suicide prevention. This approach includes both universal interventions, which strive to improve the health of the population as a whole, and tailored interventions for groups that experience higher rates of suicide and which strive to reduce health disparities between groups.


Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
NACI rapid response: Booster dose in long-term care residents and seniors living in other congregate settings

This statement contains NACI’s independent advice and recommendations, which are based upon the best current available scientific knowledge. This document is being disseminated for information purposes. People administering the vaccine should also be aware of the contents of the relevant product monograph. Recommendations for use and other information set out herein may differ from that set out in the product monographs of the Canadian manufacturers of the vaccines. Manufacturer(s) have sought approval of the vaccines and provided evidence as to its safety and efficacy only when it is used in accordance with the product monographs. NACI members and liaison members conduct themselves within the context of PHAC’s Policy on Conflict of Interest, including yearly declaration of potential conflict of interest.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
The Promoting Health Equity: Mental Health of Black Canadians Fund

As part of the new initiative on Promoting Health Equity: Mental Health of Black Canadians Fund, the Public Health Agency of Canada (PHAC) is partnering with community-based organizations, researchers and others in Black communities to generate new evidence on culturally focused programs and interventions that address mental health and its determinants for Black Canadians. This work will include supporting the implementation of this initiative by also undertaking knowledge development and capacity building efforts. The new information and evidence produced by projects under the Mental Health of Black Canadians program will be shared as it becomes available.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Adjusting public health measures in the context of COVID-19 vaccination

As COVID-19 continues to circulate in Canada and more people are getting vaccinated, different public health measures (PHMs) may be required, based on the level of transmission and other key indicators outlined below. This interim guidance provides considerations for adjusting PHMs in the context of COVID-19 vaccination in Canada. Governments and public health authorities (PHAs) across the country need to plan for these adjustments, as vaccination coverage increases in the population, the number of new and active cases decreases, and as pressures on the healthcare system and public health ease.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Dementia Strategic Fund: Awareness raising initiatives

Budget 2019 announced $50 million over 5 years to support the implementation of key elements of Canada’s first national dementia strategy. Most of Budget 2019 funding ($40M) will be administered through the Dementia Strategic Fund (DSF), which will support a variety of activities, including the development and implementation of: a national public education/awareness campaign, targeted awareness raising initiatives and initiatives that support access to and use of dementia guidance.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Dementia and ischemic heart disease comorbidity among Canadians aged 65 years and older

The Public Health Agency of Canada (PHAC) uses the Canadian Chronic Disease Surveillance System (CCDSS) to conduct national surveillance of 20 chronic conditions, including diagnosed dementia ("all types of dementia" when not specifically mentioned) and diagnosed ischemic heart disease (IHD). This publication provides the first estimates on dementia and IHD comorbidity among Canadians aged 65 years and older using data from the CCDSS. With the aging of the population, comorbidity is an area of growing interest that is being explored to better inform chronic disease policies and programs.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Lyme disease surveillance report: Preliminary annual report 2018

Zoonotic diseases are infectious diseases caused by bacteria, viruses and parasites that spread between animals and humans. Lyme disease is a multisystemic infection which can lead to health issues such as erythema migrans rash, cardiac, neurologic or arthritic manifestations. It is caused by the bacterium Borrelia burgdorferi, which is transmitted by the bite of an infected tick; the blacklegged tick, Ixodes scapularis, in Manitoba, central and eastern Canada and the western blacklegged tick, Ixodes pacificus in British Columbia. The ticks become infected after feeding on infected small mammals or birds.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Moving Forward on a Pan-Canadian Health Data Strategy

COVID-19 has highlighted issues that make it a challenge to collect, share, and use health data for the benefit of Canadians. 'Health data' includes public health, health system and population health data. Reliable, timely and relevant public health data are crucial to help public health officials provide their best advice in public health emergencies. Good health data also leads to improvements in health outcomes for Canadians in the longer term. Health data is collected and shared now, but there are important gaps.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
2020-2021 Future-Oriented Statement of Operations (Unaudited) - Public Health Agency of Canada

The Future-Oriented Statement of Operations has been prepared on the basis of government priorities and the Public Health Agency of Canada’s (the Agency) plans as described in the Departmental Plan. The information in the forecast results for fiscal year 2019-20 is based on actual results as at January 24, 2020 and on forecasts for the remainder of the fiscal year. Forecasts have been made for the planned results for fiscal year 2020-21.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Departmental Sustainable Development Strategy 2020 to 2023

The 2019 to 2022 Federal Sustainable Development Strategy (FSDS) presents the Government of Canada’s sustainable development goals and targets, as required by the Federal Sustainable Development Act. In keeping with the purpose of this Act to provide the legal framework for developing and implementing a Federal Sustainable Development Strategy that will make environmental decision-making more transparent and accountable to Parliament, the Public Health Agency of Canada (PHAC) supports the goals laid out in the FSDS through the activities described in this Departmental Sustainable Development Strategy (DSDS).

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS)

The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) monitors trends in antimicrobial use and antimicrobial resistance in selected bacterial organisms from human, animal and food sources across Canada. The program is based on several representative and methodologically unified surveillance components which can be linked to examine the relationship between antimicrobials used in food-animals and humans and the associated health impacts.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Joint Statement on Traumatic Head Injury due to Child Maltreatment (THI-CM): An update to the Joint Statement on Shaken Baby Syndrome

The Joint Statement on Shaken Baby Syndrome (SBS), originally published in 2001, was a national collaboration to recognize and provide guidance on this important public health issue. The Joint Statement on SBS required revisions to reflect developments in knowledge, understanding and practice within and between sectors. The purpose of this revised joint statement is to outline the key principles underpinning professional practice in traumatic head injury due to child maltreatment (THI-CM) in Canada.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Canadian Antimicrobial Resistance Surveillance System - Update 2020

This 2020 Canadian Antimicrobial Resistance Surveillance System (CARSS) Report provides a detailed assessment of antimicrobial resistance (AMR) in Canada. This report also provides recent information on the amount of antimicrobials used in humans and animals, as antimicrobial use (AMU) is one of the key drivers of AMR.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
National Advisory Committee on Immunization (NACI) rapid response: Additional dose of COVID-19 vaccine in immunocompromised individuals following 1- or 2- dose primary series

The National Advisory Committee on Immunization (NACI) is an External Advisory Body that provides the Public Health Agency of Canada (PHAC) with independent, ongoing and timely medical, scientific, and public health advice in response to questions from PHAC relating to immunization.

This statement contains NACI's independent advice and recommendations, which are based upon the best current available scientific knowledge. 
This document is being disseminated for information purposes. People administering the vaccine should also be aware of the contents of the relevant product monograph. Recommendations for use and other information set out herein may differ from that set out in the product monographs of the Canadian manufacturers of the vaccines. Manufacturer(s) have sought approval of the vaccines and provided evidence as to its safety and efficacy only when it is used in accordance with the product monographs. NACI members and liaison members conduct themselves within the context of PHAC's Policy on Conflict of Interest, including yearly declaration of potential conflict of interest.


Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
The Impact of the Aboriginal Head Start in Urban and Northern Communities (AHSUNC) Program on School Readiness Skills     

The Aboriginal Head Start in Urban and Northern Communities (AHSUNC) Program is a national community-based early intervention program funded by the Public Health Agency of Canada. AHSUNC focuses on early childhood development for First Nations, Inuit and Métis children and their families living off-reserve. In a study conducted by the Public Health Agency of Canada (PHAC) during the 2010–2011 school year, the Aboriginal Head Start in Urban and Northern Communities (AHSUNC) Program was found to have a positive impact on school readiness skills.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Use household chemicals safely

You probably use many household chemical products in and around your home and garage. These products may include cleaning liquids and powders, polishes, drain cleaners, paint and paint thinners, liquid laundry detergent packets and windshield washer fluids. These types of products can be dangerous and cause burns, fires, poisonings and explosions if not handled safely.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Canada-Government of Yukon Home and Community Care and Mental Health and Addictions Services Funding Agreement

Canada and Government of Yukon agreed to a Common Statement of Principles on Shared Health Priorities (hereinafter referred to as the Common Statement, attached hereto as Annex 1) on August 21, 2017, which articulated their shared vision to improve access to home and community care as well as mental health and addictions services in Canada.

Organization: Health Canada | Santé Canada
Interim update on medical assistance in dying in Canada June 17 to December 31, 2016

On June 17, 2016, An Act to amend the Criminal Code and to make related amendments to other Acts (medical assistance in dying), which permits the lawful provision of medical assistance in dying to eligible Canadians, received Royal Assent. Since then, the federal government has been working closely with provinces and territories to support its implementation.

Organization: Health Canada | Santé Canada
How to quarantine (self-isolate) at home when you may have been exposed to COVID-19 and have no symptoms

People with COVID-19 do not always recognize their early symptoms. Even if you do not have symptoms now, it is possible to transmit COVID-19 before you start showing symptoms or without ever developing symptoms. You need to quarantine (self-isolate) for 14 days at home when you may have been exposed to COVID-19 and have no symptoms.

Quarantine and isolation can help to prevent the spread of COVID-19 to others. This is especially important with the spread of variants of concern in Canada. Follow your local public health authority’s advice on when and how to quarantine or isolate. If you’ve travelled outside of Canada recently, advice for your quarantine or isolation period may be different.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
National Microbiology Laboratory

Canada's National Microbiology Laboratory (NML) is known around the world for its scientific excellence. We work with public health partners in Canada and abroad to prevent the spread of infectious diseases.  Main functions are: research, lab-based surveillance, emergency preparedness and response, specialized services to identify diseases other labs may not be able to detect or diagnose, and national and global: (leadership, networking, and capacity development).

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
Evaluating COVID-19 disease transmission and public health measures in schools: Outbreak investigation guidance

This guidance supports high quality investigations that will contribute to public health’s collective understanding of COVID-19 transmission in all types of school settings and the utility of mitigation measures implemented. A systematic approach to outbreak response, including an investigation that examines cases, contacts, their interactions and environment, will help to produce higher quality evidence and will support public health officials in making evidence informed policy decisions.
The guidelines will provide information applicable to any type of outbreak investigation and will highlight specific considerations for outbreaks occurring within an educational setting including daycares and schools.


Organization: Public Health Agency of Canada | Agence de la santé publique du Canada
National surveillance for Coronavirus disease (COVID-19)

This document outlines the recommended goals, objectives, and activities for COVID-19 surveillance in Canada. These guidelines are based on current available scientific evidence and expert opinion and are subject to change as new information becomes available. They should be read in conjunction with relevant provincial/territorial (P/T) and local legislation, regulations and policies. These guidelines have been developed based on the Canadian situation; therefore, they may differ from surveillance guidance developed by other countries.

Organization: Public Health Agency of Canada | Agence de la santé publique du Canada